Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer

Parichart Naruphontjirakul,1 Kwanchanok Viravaidya-Pasuwat1,21Biological Engineering Program, Faculty of Engineering, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand; 2Department of Chemical Engineering, Faculty of Engineering, King Mongkut’s University of Tec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naruphontjirakul P, Viravaidya-Pasuwat K
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/e14f08e3fa7345429becd538c80dd2b7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!